Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
9 13 Search
2025
A Case of Thoracic SMARCA4-deficient Pleomorphic Carcinoma Successfully Treated with Immune Checkpoint Inhibitor Combination Chemotherapy
Haigan
2025
Concurrent SMARCA4-deficient and poorly differentiated adenocarcinomas in separate lung lobes: a case report and literature review
World Journal of Surgical Oncology
2025
First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: a case report and review of the literature
Frontiers in Immunology
2025
Retrospective Insights into the Clinicopathological Features and Treatment Outcomes of Thoracic SMARCA4-Deficient Tumors
Technology in Cancer Research & Treatment
2025
Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker
Frontiers in Immunology
2025
The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma
Annals of Surgical Oncology
2025
The role of SMARCA4 in lung cancer
Scientific Reports
2025
Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis
The Oncologist
2024
A case of surgically treated non-metastatic SMARCA4-deficient undifferentiated thoracic tumor: a case report and literature review
Frontiers in Oncology
Additional cited-by details will be shown when available from Crossref